Genetic changes that affect the virulence of measles virus in a rhesus macaque model

Virology

Volumn 373, Issue 1, 2008, Pages 39-50

  Bankamp, Bettina ^a   Hodge, Gregory ^b   McChesney, Michael B ^b   Bellini, William J ^a   Rota, Paul A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Attenuation; Cell culture adaptation; Measles; Pathogenesis; Rhesus

Indexed keywords

AMINO ACID; HEMAGGLUTININ; MATRIX PROTEIN; MEASLES VACCINE; MEMBRANE COFACTOR PROTEIN; NUCLEOCAPSID PROTEIN; PHOSPHOPROTEIN; PROTEIN C; VIRUS PROTEIN V;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CHICKEN EMBRYO FIBROBLAST; CHO CELL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DISEASE MODEL; EMBRYO; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; MALE; MEASLES; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RASH; RHESUS MONKEY; SIMULATION; VERO CELL; VIRULENCE; VIRUS STRAIN; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, CD; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MACACA MULATTA; MALE; MEASLES; MEASLES VIRUS; RECEPTORS, CELL SURFACE; VERO CELLS; VIRULENCE; VIRUS REPLICATION;

CRICETULUS GRISEUS; MACACA MULATTA; MEASLES VIRUS;

EID: 40849139571     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.11.025     Document Type: Article

References (75)

1. Andres O., Obojes K., Kim K.S., ter Meulen V., and Schneider-Schaulies J. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J. Gen. Virol. 84 Pt. 5 (2003) 1189-1197
2. Anonymous. Progress in reducing global measles death: 1999-2004. Wkly. Epidemiol. Rec. 81 10 (2006) 90-94
3. Auwaerter P.G., Rota P.A., Elkins W.R., Adams R.J., DeLozier T., Shi Y., Bellini W.J., Murphy B.R., and Griffin D.E. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 180 4 (1999) 950-958
4. Bankamp B., Horikami S.M., Thompson P.D., Huber M., Billeter M., and Moyer S.A. Domains of the measles virus N protein required for binding to P protein and self-assembly. Virology 216 1 (1996) 272-277
5. Bankamp B., Wilson J., Bellini W.J., and Rota P.A. Identification of naturally occurring amino acid variations that affect the ability of the measles virus C protein to regulate genome replication and transcription. Virology 336 1 (2005) 120-129
6. Barr J.N., Whelan S.P., and Wertz G.W. Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription. J. Virol. 71 3 (1997) 1794-1801
7. Buckland R., and Wild T.F. Is CD46 the cellular receptor for measles virus?. Virus Res. 48 1 (1997) 1-9
8. Cathomen T., Naim H.Y., and Cattaneo R. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72 2 (1998) 1224-1234
9. Cattaneo R., Kaelin K., Baczko K., and Billeter M.A. Measles virus editing provides an additional cysteine-rich protein. Cell 56 5 (1989) 759-764
10. Devaux P., von Messling V., Songsungthong W., Springfeld C., and Cattaneo R. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology (2006)
11. Devereux J., Haeberli P., and Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12 1 Pt 1 (1984) 387-395
12. Domingo E., and Holland J.J. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51 (1997) 151-178
13. Dorig R.E., Marcil A., Chopra A., and Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75 2 (1993) 295-305
14. El Mubarak H.S., Yuksel S., van Amerongen G., Mulder P.G., Mukhtar M.M., Osterhaus A.D., and de Swart R.L. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J. Gen. Virol. 88 Pt 7 (2007) 2028-2034
15. Emeny J.M., and Morgan M.J. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43 1 (1979) 247-252
16. Erlenhoefer C., Wurzer W.J., Loffler S., Schneider-Schaulies S., ter Meulen V., and Schneider-Schaulies J. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 75 10 (2001) 4499-4505
17. Erlenhofer C., Duprex W.P., Rima B.K., ter Meulen V., and Schneider-Schaulies J. Analysis of receptor (CD46, CD150) usage by measles virus. J. Gen. Virol. 83 Pt 6 (2002) 1431-1436
18. Escoffier C., and Gerlier D. Infection of chicken embryonic fibroblasts by measles virus: adaptation at the virus entry level. J. Virol. 73 6 (1999) 5220-5224
19. Griffin D.E. Immune responses during measles virus infection. Curr. Top. Microbiol. Immunol. 191 (1995) 117-134
20. Griffin D.E. Measles virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. vol. 1 (2001), Lippincott Williams & Wilkins, Philadelphia, PA 1401-1441 2 vols.
21. Hashimoto K., Ono N., Tatsuo H., Minagawa H., Takeda M., Takeuchi K., and Yanagi Y. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J. Virol. 76 13 (2002) 6743-6749
22. Hausmann S., Garcin D., Delenda C., and Kolakofsky D. The versatility of paramyxovirus RNA polymerase stuttering. J. Virol. 73 7 (1999) 5568-5576
23. Hirsch R.L., Griffin D.E., Johnson R.T., Cooper S.J., Lindo de Soriano I., Roedenbeck S., and Vaisberg A. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin. Immunol. Immunopathol. 31 1 (1984) 1-12
24. Hsu E.C., Dorig R.E., Sarangi F., Marcil A., Iorio C., and Richardson C.D. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J. Virol. 71 8 (1997) 6144-6154
25. Hsu E.C., Iorio C., Sarangi F., Khine A.A., and Richardson C.D. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 279 1 (2001) 9-21
26. Jacques J.P., Hausmann S., and Kolakofsky D. Paramyxovirus mRNA editing leads to G deletions as well as insertions. EMBO J. 13 22 (1994) 5496-5503
27. Katz S.L., Milovanovic M.V., and Enders J.F. Propagation of measles virus in cultures of chick embryo cells. Proc. Soc. Exp. Biol. Med. 97 1 (1958) 23-29
28. Kobune F., Sakata H., and Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64 2 (1990) 700-705
29. Kobune F., Takahashi H., Terao K., Ohkawa T., Ami Y., Suzaki Y., Nagata N., Sakata H., Yamanouchi K., and Kai C. Nonhuman primate models of measles. Lab. Anim. Sci. 46 3 (1996) 315-320
30. Kouomou D.W., and Wild T.F. Adaptation of wild-type measles virus to tissue culture. J. Virol. 76 3 (2002) 1505-1509
31. Lamb R.A., and Kolakofsky D. Paramyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. vol. 1 (2001), Lippincott Williams & Wilkins, Philadelphia, PA 1305-1340 2 vols.
32. Lecouturier V., Fayolle J., Caballero M., Carabana J., Celma M.L., Fernandez-Munoz R., Wild T.F., and Buckland R. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70 7 (1996) 4200-4204
33. Lednicky J.A., Meehan T.P., Kinsel M.J., Dubach J., Hungerford L.L., Sarich N.A., Witecki K.E., Braid M.D., Pedrak C., and Houde C.M. Effective primary isolation of wild-type canine distemper virus in MDCK, MV1 Lu and Vero cells without nucleotide sequence changes within the entire haemagglutinin protein gene and in subgenomic sections of the fusion and phospho protein genes. J. Virol. Methods 118 2 (2004) 147-157
34. Liszewski M.K., Post T.W., and Atkinson J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9 (1991) 431-455
35. Manchester M., Eto D.S., Valsamakis A., Liton P.B., Fernandez-Munoz R., Rota P.A., Bellini W.J., Forthal D.N., and Oldstone M.B. Clinical isolates of measles virus use CD46 as a cellular receptor. J. Virol. 74 9 (2000) 3967-3974
36. Masse N., Barrett T., Muller C.P., Wild T.F., and Buckland R. Identification of a second major site for CD46 binding in the hemagglutinin protein from a laboratory strain of measles virus (MV): potential consequences for wild-type MV infection. J. Virol. 76 24 (2002) 13034-13038
37. McChesney M.B., Fujinami R.S., Lerche N.W., Marx P.A., and Oldstone M.B. Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J. Infect. Dis. 159 4 (1989) 757-760
38. McChesney M.B., Miller C.J., Rota P.A., Zhu Y.D., Antipa L., Lerche N.W., Ahmed R., and Bellini W.J. Experimental measles: I. Pathogenesis in the normal and the immunized host. Virology 233 1 (1997) 74-84
39. McKimm J., and Rapp F. Variation in ability of measles virus plaque progeny to induce interferon. Proc. Natl. Acad. Sci. U. S. A. 74 7 (1977) 3056-3059
40. Miyajima N., Takeda M., Tashiro M., Hashimoto K., Yanagi Y., Nagata K., and Takeuchi K. Cell tropism of wild-type measles virus is affected by amino acid substitutions in the P, V and M proteins, or by a truncation in the C protein. J. Gen. Virol. 85 Pt 10 (2004) 3001-3006
41. Naim H.Y., Ehler E., and Billeter M.A. Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J. 19 14 (2000) 3576-3585
42. Naniche D., Varior-Krishnan G., Cervoni F., Wild T.F., Rossi B., Rabourdin-Combe C., and Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67 10 (1993) 6025-6032
43. Nielsen L., Andersen M.K., Jensen T.D., Blixenkrone-Moller M., and Bolt G. Changes in the receptor binding haemagglutinin protein of wild-type morbilliviruses are not required for adaptation to Vero cells. Virus Genes 27 2 (2003) 157-162
44. Nielsen L., Blixenkrone-Moller M., Thylstrup M., Hansen N.J., and Bolt G. Adaptation of wild-type measles virus to CD46 receptor usage. Arch. Virol. 146 2 (2001) 197-208
45. Ohno S., Ono N., Takeda M., Takeuchi K., and Yanagi Y. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 85 Pt 10 (2004) 2991-2999
46. Ono N., Tatsuo H., Hidaka Y., Aoki T., Minagawa H., and Yanagi Y. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75 9 (2001) 4399-4401
47. Parks C.L., Lerch R.A., Walpita P., Wang H.P., Sidhu M.S., and Udem S.A. Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage. J. Virol. 75 2 (2001) 921-933
48. Parks C.L., Lerch R.A., Walpita P., Wang H.P., Sidhu M.S., and Udem S.A. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J. Virol. 75 2 (2001) 910-920
49. Plemper R.K., Hammond A.L., Gerlier D., Fielding A.K., and Cattaneo R. Strength of envelope protein interaction modulates cytopathicity of measles virus. J. Virol. 76 10 (2002) 5051-5061
50. Premenko-Lanier M., Rota P.A., Rhodes G.H., Bellini W.J., and McChesney M.B. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J. Infect. Dis. 189 11 (2004) 2064-2071
51. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dotsch C., Christiansen G., and Billeter M.A. Rescue of measles viruses from cloned DNA. EMBO J. 14 23 (1995) 5773-5784
52. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27 (1938) 493-497
53. Reutter G.L., Cortese-Grogan C., Wilson J., and Moyer S.A. Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology 285 1 (2001) 100-109
54. Riddell M.A., Rota J.S., and Rota P.A. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras. Virol. J. 2 (2005) 87
55. Rivals J.P., Plattet P., Currat-Zweifel C., Zurbriggen A., and Wittek R. Adaptation of canine distemper virus to canine footpad keratinocytes modifies polymerase activity and fusogenicity through amino acid substitutions in the P/V/C and H proteins. Virology 359 1 (2006) 6-18
56. Rota J.S., Hummel K.B., Rota P.A., and Bellini W.J. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188 1 (1992) 135-142
57. Rota J.S., Wang Z.D., Rota P.A., and Bellini W.J. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res. 31 3 (1994) 317-330
58. Shaffer J.A., Bellini W.J., and Rota P.A. The C protein of measles virus inhibits the type I interferon response. Virology 315 2 (2003) 389-397
59. Stillman E.A., and Whitt M.A. Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts. J. Virol. 71 3 (1997) 2127-2137
60. Tahara M., Takeda M., and Yanagi Y. Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses. J. Virol. 79 24 (2005) 15218-15225
61. Tahara M., Takeda M., and Yanagi Y. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion. J. Virol. 81 13 (2007) 6827-6836
62. Takeda M., Kato A., Kobune F., Sakata H., Li Y., Shioda T., Sakai Y., Asakawa M., and Nagai Y. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72 11 (1998) 8690-8696
63. Takeuchi K., Kadota S.I., Takeda M., Miyajima N., and Nagata K. Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett. 545 2-3 (2003) 177-182
64. Takeuchi K., Miyajima N., Kobune F., and Tashiro M. Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient. Virus Genes 20 3 (2000) 253-257
65. Takeuchi K., Takeda M., Miyajima N., Kobune F., Tanabayashi K., and Tashiro M. Recombinant wild-type and edmonston strain measles viruses bearing heterologous H proteins: role of H protein in cell fusion and host cell specificity. J. Virol. 76 10 (2002) 4891-4900
66. Tamashiro V.G., Perez H.H., and Griffin D.E. Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr. Infect. Dis. J. 6 5 (1987) 451-454
67. Tatsuo H., Ono N., Tanaka K., and Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406 6798 (2000) 893-897
68. Tober C., Seufert M., Schneider H., Billeter M.A., Johnston I.C., Niewiesk S., ter Meulen V., and Schneider-Schaulies S. Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72 10 (1998) 8124-8132
69. van Binnendijk R.S., van der Heijden R.W., van Amerongen G., UytdeHaag F.G., and Osterhaus A.D. Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J. Infect. Dis. 170 2 (1994) 443-448
70. WHO. Global measles and rubella laboratory network-update. Wkly. Epidemiol. Rec. 80 44 (2005) 384-388
71. Witko S.E., Kotash C., Sidhu M.S., Udem S.A., and Parks C.L. Inhibition of measles virus minireplicon-encoded reporter gene expression by V protein. Virology 348 1 (2006) 107-119
72. Wolfson L.J., Strebel P.M., Gacic-Dobo M., Hoekstra E.J., McFarland J.W., and Hersh B.S. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 369 9557 (2007) 191-200
73. Yanagi Y., Ono N., Tatsuo H., Hashimoto K., and Minagawa H. Measles virus receptor SLAM (CD150). Virology 299 2 (2002) 155-161
74. Yanagi Y., Takeda M., and Ohno S. Measles virus: cellular receptors, tropism and pathogenesis. J. Gen. Virol. 87 Pt 10 (2006) 2767-2779
75. Zhu Y.D., Heath J., Collins J., Greene T., Antipa L., Rota P., Bellini W., and McChesney M. Experimental measles: II. Infection and immunity in the rhesus macaque. Virology 233 1 (1997) 85-92